SPP1 + macrophage-induced CD74 + tumor cells promote adrenocortical carcinoma tumor thrombus via the SPP1/CD44/JAK/STAT signaling
Journal for ImmunoTherapy of Cancer · 2026
DOI: 10.1136/jitc-2026-015080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2026. Verfasst von Houliang Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, China. Hauptthemen laut MEDLINE: Adrenocortical Carcinoma, Osteopontin, Macrophages, Antigens, Differentiation, B-Lymphocyte. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Basic Research Program of Jiangsu Province, National clinical key discipline construction funds, Jiangsu Provincial Key Discipline and Laboratory Construction Funds of Urology.
Abstract (Originalsprache)
Adrenocortical carcinoma (ACC) is a rare and highly aggressive endocrine malignancy with limited treatment options and poor prognosis. Venous tumor thrombus (VTT) is a common complication associated with ACC progression, yet the cellular and molecular mechanisms driving VTT formation remain largely unknown. We performed integrated single-cell RNA sequencing and spatial transcriptomics on paired samples of primary tumor, VTT tail, and VTT head obtained from one ACC patient, followed by in vitro and in vivo functional validation. Our results identified a distinct CD74 + tumor cell subcluster enriched in the VTT head region, and functional assays demonstrated that CD74 significantly enhances ACC cell migration, invasion, and proliferation through activation of the JAK-STAT signaling pathway. Moreover, spatial and ligand-receptor analyses revealed that SPP1 + macrophages closely interact with CD74 + tumor cells via the SPP1-CD44 axis. Functional experiments confirmed that SPP1 secreted by macrophages potentiates CD74-induced JAK-STAT activation and malignant phenotypes. Collectively, we found that CD74 + tumor cells drive ACC progression under the regulation of the SPP1-CD44 signaling pathway in the vicinity of SPP1 + macrophages, thereby revealing a novel mechanistic axis with therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, China.
- School of Medicine, Southeast University, Nanjing, China.
- Medical College, Institute of Translational Medicine, Yangzhou University, Yangzhou, China.
- Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, China maoweipu88@163.com mingchen0712@126.com 520chenyu1018@163.com Doctorwujianping@126.com.
Förderung
- Basic Research Program of Jiangsu Province
- National clinical key discipline construction funds
- Jiangsu Provincial Key Discipline and Laboratory Construction Funds of Urology
- Jiangsu Provincial Postgraduate Research and Practice Innovation Program
- National Natural Science Foundation of China
Zitieren
APA
Zhang, H., Xu, K., Zhen, L., Jiang, Y., Chou, A., Chen, M., Chen, Y., Wu, J., & Mao, W. (2026). SPP1 + macrophage-induced CD74 + tumor cells promote adrenocortical carcinoma tumor thrombus via the SPP1/CD44/JAK/STAT signaling. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2026-015080
Vancouver
Zhang H, Xu K, Zhen L, Jiang Y, Chou A, Chen M, et al. SPP1 + macrophage-induced CD74 + tumor cells promote adrenocortical carcinoma tumor thrombus via the SPP1/CD44/JAK/STAT signaling. Journal for ImmunoTherapy of Cancer. 2026. doi:10.1136/jitc-2026-015080
BibTeX
@article{Zhang2026,
author = {Zhang, Houliang and Xu, Kangjie and Zhen, Lan and Jiang, Yanji and Chou, Anyang and Chen, Ming and Chen, Yu and Wu, Jianping and Mao, Weipu},
title = {SPP1 + macrophage-induced CD74 + tumor cells promote adrenocortical carcinoma tumor thrombus via the SPP1/CD44/JAK/STAT signaling},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
doi = {10.1136/jitc-2026-015080}
}
EUVIMED